HyperChange | Sengine Is HyperChanging Cancer Treatment 🔬 @HyperChangeTV | Uploaded August 2021 | Updated October 2024, 4 hours ago.
Going behind the scenes of Sengine Precision Medicine, a biotech startup based in Seattle, WA. Sengine is changing the way we understand and treat cancer using novel screening technologies, leading the personalized medicine revolution. Shoutout to my mom for being a legend and founding/running Sengine she is a huge inspiration to me :)
SEngine website: senginemedicine.com
For patients: contact us at care@senginemedicine.com and our clinical coordinators will help you find out if the PARIS® test applies to your cancer. Note that, the test does not always identify a drug that may work for you, the current success is ~70%, thus 2 in 3 chances of identifying a potential drug match for your cancer. The PARIS® test will also identify treatments that will not work, thus sparing unnecessary costs and saving precious time. For all other inquiries, including interested, media and investors, email us at connect@senginemedicine.com
Disclaimer: This video is purely my opinion and should not be regarded as factual information. I am not a financial advisor. This is not a recommendation to buy or sell securities. Do not assume any facts and numbers in this video are accurate. Always do your own due diligence.
As of 08/19/2021 I'm invested in the following companies/startups/assets: Tesla, SpaceX, Bitcoin, Ethereum, Unisocks, JOYToys, Square, Arcimoto, Dogecoin, Snap, NFTX, Rainbow Wallet, Atoms, Carta, Pipe, Alloy Automation, Genies, DMN8, Haus, Community, Dadi, Pigeon Loans & others.
Going behind the scenes of Sengine Precision Medicine, a biotech startup based in Seattle, WA. Sengine is changing the way we understand and treat cancer using novel screening technologies, leading the personalized medicine revolution. Shoutout to my mom for being a legend and founding/running Sengine she is a huge inspiration to me :)
SEngine website: senginemedicine.com
For patients: contact us at care@senginemedicine.com and our clinical coordinators will help you find out if the PARIS® test applies to your cancer. Note that, the test does not always identify a drug that may work for you, the current success is ~70%, thus 2 in 3 chances of identifying a potential drug match for your cancer. The PARIS® test will also identify treatments that will not work, thus sparing unnecessary costs and saving precious time. For all other inquiries, including interested, media and investors, email us at connect@senginemedicine.com
Disclaimer: This video is purely my opinion and should not be regarded as factual information. I am not a financial advisor. This is not a recommendation to buy or sell securities. Do not assume any facts and numbers in this video are accurate. Always do your own due diligence.
As of 08/19/2021 I'm invested in the following companies/startups/assets: Tesla, SpaceX, Bitcoin, Ethereum, Unisocks, JOYToys, Square, Arcimoto, Dogecoin, Snap, NFTX, Rainbow Wallet, Atoms, Carta, Pipe, Alloy Automation, Genies, DMN8, Haus, Community, Dadi, Pigeon Loans & others.
